Penumbra Inc (STU:0P8)
€ 212.2 2.5 (1.19%) Market Cap: 8.20 Bil Enterprise Value: 8.14 Bil PE Ratio: 266.87 PB Ratio: 7.97 GF Score: 87/100

Penumbra Inc at Wells Fargo Virtual Healthcare Conference Transcript

Sep 09, 2021 / 04:40PM GMT
Release Date Price: €229 (+0.09%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

All right. Good afternoon for those of you on the East Coast, and good morning for those of you on the West Coast. I'm Larry Biegelsen, the medical device analyst. And it's my pleasure to host this session with the management team -- or the CEO, I should say, of Penumbra, Adam Elsesser. In terms of format, it's going to be a fireside chat. (Operator Instructions) We're going to try with the polling questions, which have been going pretty well.

And I think that's it. Adam, thanks for joining us.

Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO

Yes. Thanks for having us.

Questions & Answers

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

All right. So why don't we jump in start with the COVID question, unfortunately? Next year, hopefully, we won't be asking about COVID. But just I'd love

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot